Fiera Capital (Canada)
SGMO

Fiera Capital (Canada)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Fiera Capital (Canada)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-34,855
Closed -$590K – 721
2018
Q3 		$590K Sell
34,855
-20,714
-37% -$315K ﹤0.01% 543
2018
Q2 		$789K Sell
55,569
-5,096
-8% -$84.7K ﹤0.01% 496
2018
Q1 		$1.15M Buy
+60,665
New +$1.3M 0.01% 437

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fiera Capital (Canada)'s SGMO Position: Q4 2018 in Review

Fiera Capital (Canada) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2018, closing a stake of 34,855 shares — an estimated $590K sold.

Fiera Capital (Canada) first reported a position in SGMO in Q1 2018 and held it in 3 quarters. The position peaked at $1.15M in Q1 2018. 197 funds tracked by Wall St. Rank hold SGMO as of Q4 2018.

  • Fiera Capital (Canada) reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2018 after selling out during the quarter.
  • Fiera Capital (Canada) sold 34,855 SANGAMO THERAPEUTICS INC shares in Q4 2018, an estimated $590K.
  • Fiera Capital (Canada) first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 3 quarters.
  • Fiera Capital (Canada)'s SANGAMO THERAPEUTICS INC position peaked at $1.15M in Q1 2018.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2018.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2018, filed 12 Feb 2019.